DaBomb Protein Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	139.81	132.17	253.59	379.99	195.18	197.14
Trading Asset Securities	-	-	-	0.08	-	-
Cash & Short-Term Investments	168.72	132.17	253.59	380.07	195.18	197.14
Cash Growth	-24.31%	-47.88%	-33.28%	94.73%	-0.99%	-25.78%
Accounts Receivable	52.19	39.97	32.28	51.25	36.99	56.04
Other Receivables	1.46	2.12	2.76	1.08	1.44	1.07
Receivables	53.65	42.09	35.05	52.34	38.42	57.11
Inventory	29.8	19.05	34.07	20.23	52.79	37.68
Prepaid Expenses	3.77	3.9	3.87	4.89	19.54	39.97
Other Current Assets	-	28.47	327.59	321.31	36.84	69.73
Total Current Assets	255.94	225.68	654.16	778.83	342.76	401.62
Property, Plant & Equipment	829.82	832.71	621.59	564.83	888.09	876.14
Long-Term Investments	-	-	-	-	0.18	0.04
Other Intangible Assets	0.17	0.19	0.21	0.19	0.28	0.37
Long-Term Deferred Tax Assets	5.41	7.29	8.55	12.31	13.85	9.2
Other Long-Term Assets	29.39	29.9	30.76	45.74	34.92	49.12
Total Assets	1,121	1,096	1,315	1,402	1,280	1,336
Accounts Payable	16.05	12.59	13.9	9.14	28.5	10.47
Accrued Expenses	-	7.33	12.88	11.05	11.8	17.22
Short-Term Debt	38	28	90	92	95	161
Current Portion of Long-Term Debt	20.42	26.18	30.98	238.29	66.66	18.47
Current Portion of Leases	0.35	0.52	1.14	0.98	1.37	1.51
Current Unearned Revenue	0.27	0.03	-	0.23	2.4	-
Other Current Liabilities	22.88	9.84	30.09	5.08	12.64	13.86
Total Current Liabilities	97.97	84.49	178.98	356.77	218.37	222.53
Long-Term Debt	9.73	19.43	45.41	85.7	330.94	433.22
Long-Term Leases	-	0.09	0.6	0.63	1.61	3.81
Long-Term Unearned Revenue	-	-	0.22	0.65	1.42	2.41
Long-Term Deferred Tax Liabilities	3.68	2.48	0.75	0.08	0.55	0.28
Total Liabilities	111.38	106.48	225.96	443.83	552.88	662.24
Common Stock	719.42	719.42	679.86	597.1	395.14	330.82
Additional Paid-In Capital	271.78	338.7	355.25	344.46	286.31	246.9
Retained Earnings	26.45	-55.26	26.31	4.3	61.32	105.98
Comprehensive Income & Other	-8.29	-13.59	27.89	12.21	-15.56	-9.46
Shareholders' Equity	1,009	989.28	1,089	958.06	727.2	674.24
Total Liabilities & Equity	1,121	1,096	1,315	1,402	1,280	1,336
Total Debt	68.5	74.21	168.13	417.6	495.59	618.01
Net Cash (Debt)	100.23	57.96	85.45	-37.53	-300.41	-420.87
Net Cash Growth	16.84%	-32.18%	-	-	-	-
Net Cash Per Share	1.36	0.81	1.19	-0.70	-7.76	-12.96
Filing Date Shares Outstanding	70.68	71.94	67.99	59.71	39.51	33.08
Total Common Shares Outstanding	70.68	71.94	67.99	59.71	39.51	33.08
Working Capital	157.97	141.19	475.19	422.07	124.39	179.09
Book Value Per Share	14.28	13.75	16.02	16.05	18.40	20.38
Tangible Book Value	1,009	989.09	1,089	957.88	726.92	673.88
Tangible Book Value Per Share	14.28	13.75	16.02	16.04	18.40	20.37
Land	-	401.07	401.07	401.07	401.07	400.92
Buildings	-	313.83	138.81	133.06	320.83	317.42
Machinery	-	304.77	187.52	177.46	291.48	256.69
Construction In Progress	-	1.56	51.76	-	0.24	1.42
Leasehold Improvements	-	51.75	25.83	25.31	54.72	53.41